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Background: Lateral epicondylitis is the most frequent cause of pain around the elbow joint. It causes pain in the
region of the elbow joint and results in dysfunction of the elbow and deterioration of the quality of life. The
purpose of this study is to compare the effects of ipsilateral acupuncture, contralateral acupuncture and sham
acupuncture on lateral epicondylitis.
Methods/design: Forty-five subjects with lateral epicondylitis will be randomized into three groups: the ipsilateral
acupuncture group, contralateral acupuncture group and the sham acupuncture group. The inclusion criteria will
be as follows: (1) age between 19 and 65 years with pain due to one-sided lateral epicondylitis that persisted for at
least four weeks, (2) with tenderness on pressure limited to regions around the elbow joint, (3) complaining of pain
during resistive extension of the middle finger or the wrist, (4) with average pain of NRS 4 or higher during the last
one week at a screening visit and (5) voluntarily agree to this study and sign a written consent. Acupuncture
treatment will be given 10 times in total for 4 weeks to all groups. Follow up observations will be conducted after
the completion of the treatment, 8 weeks and 12 weeks after the random assignment. Ipsilateral acupuncture
group and contralateral acupuncture group will receive acupuncture on LI4, TE5, LI10, LI11, LU5, LI12 and two Ashi
points. The sham acupuncture group will receive treatment on acupuncture points not related to the lateral
epicondylitis using a non-invasive method. The needles will be maintained for 20 minutes. The primary outcome
will be differences in the visual analogue scale (VAS) for elbow pain between the groups. The secondary outcome
will be differences in patient-rated tennis elbow evaluation (PRTEE), pain-free/maximum grip strength (Dynamometer),
pressure pain threshold, clinically relevant improvement, patient global assessment, and the EQ-5D. The data will be
analyzed with the paired t-test and ANCOVA (P <0.05).
Discussion: The results of this study will allow evaluation of contralateral acupuncture from two aspects. First, if the
contralateral acupuncture shows the effects similar to ipsilateral acupuncture, this will establish clinical basis for
contralateral acupuncture. Second, if the effects of contralateral acupuncture are not comparable to the effects of
ipsilateral acupuncture, but are shown to be similar to the effects of the sham acupuncture, we can establish the basis
for using the same acupoints of the unaffected side as a control in acupuncture clinical studies.
Trial registration: This trial has been registered with the ‘Clinical Research Information Service (CRIS)’, Republic of Korea:
KCT0000628.
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Lateral epicondylitis is a disease that can result in elbow
joint pain and dysfunction, and decrease in the quality
of life [1]. Lateral epicondylitis is the most common
cause of pain around the elbow joint, and occurs be-
cause of overuse injury and repetitive stress [1,2]. Every
year, about 1 to 3% of the general population is affected
[3], and there is no difference in morbidity between the
sexes, but the prevalence rate is higher in people over 40
years of age [4]. In addition, it is more frequent in the
dominant arm [5], and if untreated the symptoms persist
for 6 to 24 months [6-8].
Treatment for lateral epicondylitis includes non-steroidal
anti-inflammatory drugs (NSAIDs), corticosteroid injec-
tion, botulinum toxin injection, extracorporeal shock wave
therapy, low-level laser therapy, physiotherapy, acupunc-
ture, and surgery [4]. The short-term effect of ultrasound
therapy [9], low-level laser therapy [10], and acupuncture
[11,12] has been accepted, but there is insufficient evidence
regarding their long-term effects [13]. Further, the short-
term effects of injection treatments have been accepted,
but problems such as adverse events and high frequency of
relapse, still exist [14-16].
Previous studies of lateral epicondylitis include a case
study of fire needle therapy [17], and randomized con-
trolled trials (RCTs) comparing the effects of acupunc-
ture against sham acupuncture [18-20], physical therapy
[21], and electro-acupuncture [22]. Sham acupuncture,
which is used in clinical studies of acupuncture, includes
invasive and noninvasive methods. The acupoint used as
the control includes the actual acupoint used in the treat-
ment, areas away from the actual acupoint (non-acupoint),
or acupoints unrelated to the specific indication. Sham
acupuncture used as controls in previous studies of lateral
epicondylitis includes using areas away from the acupoint
(non-acupoint) [18], minimal acupuncture at the same
acupoint [20], and non-invasive acupuncture at an unre-
lated acupoint [19]. However, in clinical studies of acu-
puncture, one of the problems of using sham acupuncture
is that practitioner blinding is not done.
Contralateral acupuncture is a traditional acupuncture
technique, whereby acupuncture points on the right side
are selected for diseases or disorder on the left and vice
versa [23]. Several studies have shown effects of contra-
lateral acupuncture on hemihidrosis [24], herpes zoster
[24], dizziness [25], pain [24,26-29] and stroke [30]. Fur-
thermore, there have been studies comparing the brain
function [31], the change ratio of mean blood flux [32],
and the blood volume [33] of the needle-inserted side
and the side without insertion after insertion at acupoints,
such as the LI4 and ST36, on normal subjects. However,
there have not been any studies on lateral epicondylitis
comparing ipsilateral acupuncture and contralateral acu-
puncture at the same acupoints.Therefore, this study is a randomised, practitioner-
blinded, parallel-group, sham-controlled pilot study of
patients with lateral epicondylitis, to compare the effi-
cacy of ipsilateral acupuncture, contralateral acupunc-
ture, and sham acupuncture (non-invasive acupuncture
at an unrelated acupoint). Especially, this study is designed
to conduct a practitioner-blinded study by setting up sep-
arate groups of diagnosticians and practitioners in an at-
tempt to examine the possibility of a practitioner-blinded
clinical trial.
Methods/design
Aim of the study
The aim of this pilot study is to assess the efficacy of
unaffected-side acupuncture by comparing the efficacy
of ipsilateral acupuncture, contralateral acupuncture and
placebo acupuncture in patients with lateral epicondyl-
itis. And through this study, we will evaluate the possi-
bility of a practitioner-blinded clinical trial.
Study design
This study is a randomised, practitioner-blinded (to
affected side), parallel-group, placebo-controlled pilot
study of patients with lateral epicondylitis. The subjects
who voluntarily sign a consent form will undergo the
examinations according to the clinical study design.
When a subject is determined to be appropriate for
participation based on the inclusion and exclusion cri-
teria, the subject will be randomly assigned to one of
three groups during the second visit (Table 1). Treat-
ments will be performed two to three times a week. All
three groups receive 10 acupuncture treatments over 4
weeks. A once-a-week treatment and a four-times-a-
week treatment will be permitted to minimize the dif-
ferences in the total number of treatments. Follow up
observations will be conducted at the end of 4, 8 and at
12 weeks after randomized assignment. The affected-
and unaffected-side acupoints were selected based on
acupuncture literature and prior studies [18,20,21]. The
acupoints for the control group were selected after refer-
ring to a previous study [19], with six acupoints added to
maintain the same number of treated acupoints between
the groups. To summarize, all three groups will receive
acupunctures at eight acupoints (Figure 1).
The practitioner and diagnostician have had more
than 4 years of clinical experience since completing a
6-year-long college of Korean medicine and have received
a Doctor of Korean Medicine.
Randomization and allocation concealment
This study is designed as a pilot study and allowing
for a 20% dropout rate, each group will include 15
participants [34,35]. Participants will be assigned with a
1:1:1 allocation ratio according to a computer-generated
Table 1 Patient inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
1. Individuals between the ages of 19 and 65 years with lateral
epicondylitis on one arm and pain persisting for at least 4 weeks
1. Individuals whose radiological examinations show abnormalities such as
calcification, arthritis, and inflammatory arthropathy of the elbow joint
2. Individuals with tenderness limited to the elbow joint and
surrounding area
2. Individuals with a history of trauma, ligament damage, fracture, tumor,
or surgery of the elbow joint
3. Individuals reporting pain under resisted extension of the middle
finger and wrist
3. Individuals who have been diagnosed with or treated for cervical
radiculopathy or herniation of intervertebral disc
4. Individuals with an average pain of 40 or more (0 to 100) on the
visual analogue scale) in the week prior to the screening visit
4. Individuals who have received injections for lateral epicondylitis during
the last 6 months
5. Individuals who volunteered to participate in the study and who
signed a consent form
5. Individuals who have received treatments such as non-steroidal anti-
inflammatory drugs, acupuncture, physiotherapy for lateral epicondylitis
during the last 2 weeks
6. Individuals judged by the person in charge of the clinical trial as unsuitable
for participation, such as those with mental disorders, who are pregnant, or
have other acute or chronic disorders
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dominant hand, as left- or right-handed. The allocation
will be concealed in sequentially numbered, opaque,
sealed envelopes and the random allocation envelops
will be opened only after the participant has satisfied all
selection criteria and completed baseline assessments.
The participants and diagnostician will know the allo-
cated group but the practitioners, outcome assessors
and data analysts will not.Figure 1 Flowchart of the study design.Practitioner blinding
Practitioner blinding will be confirmed by separately in-
volving diagnosticians and practitioners in the study.
The practitioner will not participate in the screening and
random assignment so will be unaware of the affected
side. On screening and before each acupuncture treat-
ment session, the diagnostician will assess the Ashi-
points of the subjects. The diagnostician will mark and
describe the subjects’ Ashi-points on a diagram of the
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after confirming only the side assigned for treatment.
Appropriateness of practitioner blinding will be assessed
after the end of the treatment.
Ethics
This protocol adheres to the principles of the Declar-
ation of Helsinki and has been approved by the institu-
tional review boards of the Daejeon University Hospital,
where the study will take place (djomc-100-1), and writ-
ten consent will be obtained from each participant be-
fore any treatment is given. All patients will have the
right to withdraw from the study at any time.
Inclusion criteria
1. Individuals between the ages of 19 and 65 years with
lateral epicondylitis on one arm and pain persisting
for at least 4 weeks.
2. Individuals with tenderness limited to the elbow
joint and surrounding area.
3. Individuals reporting pain under resisted extension
of the middle finger and wrist.
4. Individuals with an average pain of 40 or more (0–100)
on the visual analogue Scale (VAS) in the week prior
to the screening visit.
5. Individuals who volunteered to participate in the
study and who signed a consent form.
Exclusion criteria
1. Individuals whose radiological examinations show
abnormalities such as calcification, arthritis, and
inflammatory arthropathy of the elbow joint.
2. Individuals with a history of trauma, ligament damage,
fracture, tumor, or surgery of the elbow joint.
3. Individuals who have been diagnosed with or treated
for cervical radiculopathy or herniation of
intervertebral disc.
4. Individuals who have received injections for lateral
epicondylitis during the last 6 months.
5. Individuals who have received treatments such as
non-steroidal anti-inflammatory drugs (NSAIDs),
acupuncture, physiotherapy for lateral epicondylitis
during the last 2 weeks.
6. Individuals judged by the person in charge of the
clinical trial as unsuitable for participation, such as
those with mental disorders, who are pregnant, or
have other acute or chronic disorders.
Interventions
Ipsilateral acupuncture group
The subjects will receive 10 treatments for 4 weeks.
Treatments will be performed two to three times a week,at a minimum of one per week and a maximum of four
per week. The acupoints that will be used are as follows:
LI4, TE5, LI10, LI11, LU5, LI12, and two Ashi-points.
Sterilized disposable acupuncture needles of size 0.25 ×
30 mm will be used. Deqi will be induced by manual
stimulation, where the needles will be inserted for 20
minutes and then removed.
Contralateral acupuncture group
The subjects in the contralateral acupuncture group will re-
ceive the same frequency, duration, and total number of
treatments as the ipsilateral acupuncture group. Needles
will be inserted at the same acupoints of the unaffected side
by using the same manual technique and retaining time.
Control group
For the control group, the acupoints used (BL13, Bl14,
Bl15, and Bl16 of both the sides) are unrelated to the
treatment of lateral epicondylitis, and non-invasive tech-
niques will be used, namely, the Park sham placebo acu-
puncture device [36]. The subjects in the control group
will receive the same frequency, duration, and total num-
ber of treatments and retaining time as the ipsilateral and
contralateral acupuncture groups.
Prohibited concomitant treatments
During the treatment period, the subjects will be
prohibited from receiving any concomitant treatments for
the lateral epicondylitis. And the subjects will be allowed
to decide whether to receive additional treatment during
the assessment period. Any other related treatments will
be recorded in detail.
Outcomes
Primary outcome measure
The primary outcome measure in this study is the differ-
ence in visual analog scale (VAS) for elbow pain between
the groups at 4 weeks after random assignment. The in-
tensity of perceived pain of the elbow in the past week
will be measured using a VAS consisting of a 100-mm
horizontal line, where the left end indicates no pain, and
the right end indicates maximum pain.
Secondary outcome measures
The secondary outcome measures are the difference
in VAS for elbow pain between the groups at 8 and 12
weeks after random assignment, and the differences in
patient-rated tennis elbow evaluation (PRTEE), pain-
free/maximum grip strength, pressure pain threshold,
clinically relevant improvement, patient global assess-
ment and EuroQol between the groups at 4, 8, and 12
weeks after random assignment.
PRTEE, a tool specifically developed to assess lateral
epicondylitis [37], will be used. PRTEE is composed of
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free/maximum grip strength will be measured using a
dynamometer (Baseline® Digital Smedley Spring Dyna-
mometer, Fabrication Enterprises, Inc., Irvington, New
York, USA). The subjects will be asked to take a
shoulder-width stance and allow their arms to hang loose.
The pain-free grip strength will be measured, followed by
the measurement of the maximum grip strength, and the
affected side will be measured first and then the unaffected
side. The measurement readings will be not revealed to the
subjects until the completion of the test. The pain-free grip
strength will be measured up to the point when the subject
feels uneasy. The maximum grip strength will be measured
at the maximum grip level. While administering a perpen-
dicular pressure on the common extensor tendon area with
a maximum pressure of 6 kg/cm2 by using a pressure
algometer (PainTest™ FPX 25 Algometer, Wagner Instru-
ments, Greenwich, CT, USA), the measurement will be
taken at the moment when the sensation of pressure
changes to pain. The mean value of three measurements
taken at an interval of 20 seconds will be used [39]. Clinic-
ally relevant improvement will be defined when a 50% de-
crease in VAS is observed before and after the treatment.
Quality of life will be measured using the Korean version
of the EuroQol-5D (EQ-5D) tool [40]. Self-perceived im-
provements will be assessed by comparing sensations be-
fore and after the treatment using the patient global
assessment (PGA) scale [41]. Subjects can select one of the
following five responses to describe the improvement of
symptoms when compared to that before the treatment:
greatly improved; somewhat improved; no changes; some-
what exacerbated; and greatly exacerbated. A varied and
translated version of the psychometric properties of the
credibility/expectancy questionnaire [42] will be used to
measure the credibility and expectancy of the subjects.
From this questionnaire, the expectations of the subjects in
relation to acupuncture therapy can be determined. Fur-
thermore, differences in acupuncture efficacy depending
on expectations can be assessed. In this study, we will be
using the Southampton Needle Sensation Questionnaire
[43] to assess the sensation that the subjects experience
after the first acupuncture treatment. To determine
whether practitioner blinding will be done appropriately,
the practitioners will be asked to guess the group to which
each of the subjects belongs.
Follow up
Follow up observations will be conducted at 8 and 12
weeks after the random assignment.
Statistical analysis
Analysis of covariance (ANCOVA) will be performed,
with the primary analysis variables and relative changes
in the values of secondary analysis variables, at the 4th,8th and 12th week, compared to the baseline values, as
dependent variables. The baseline value will be set as a
covariate and the group as the fixed factor. The statistical
significance threshold will be set at 0.05 (two-sided), with
the 95% confidence interval. Missing data will be handled
with the mixed model for repeated measures (MMRM)
under the assumption that observations are missing at ran-
dom (MAR). Safety analysis will be performed by analyzing
the frequency of adverse events suspected as related to the
treatment, and serious adverse events. The data for adverse
events will be collected through the symptoms reported by
the patients, and observations by a researcher at every visit.
Among the variables for the primary outcome, sub analysis
can be performed to determine whether the pain area of
the subjects, faith in acupuncture treatment, and credibility
of the efficacy of acupuncture treatment affect actual im-
provements in pain. Regression analysis can be performed
to find the variables that have an influence on pain reduc-
tion. We will use the SAS® version 9.3 (SAS institute. Inc.,
Cary, NC, USA) for statistical analysis.
Adverse events
The subjects will be requested to voluntarily report infor-
mation about adverse events, and the researcher will con-
firm the occurrence of adverse events through methods
such as a medical interview. Details about adverse events,
such as the date of occurrence, lost time, degree of adverse
events, measures taken related to the treatment, causal re-
lationship with the treatment, other treatments or medica-
tions that are suspected to cause the adverse event, and
treatment of the adverse event, will be recorded in detail.
Discussion
By using the results of our study, we plan to evaluate two
aspects of contralateral acupuncture. First, if the contralat-
eral acupuncture shows similar efficacy to the ipsilateral
acupuncture, we can establish the clinical basis for contra-
lateral acupuncture. Second, if contralateral acupuncture is
not as efficacious as ipsilateral acupuncture and is similar
to sham acupuncture, then we can establish the basis for
using the same acupoints of the unaffected side as a con-
trol in acupuncture clinical studies. In other words, in dis-
eases where either one of the left or right sides is affected,
such as diseases of the shoulder joint, elbow joint, knee
joint, or ankle joint, the contralateral acupuncture could
serve as areas where sham acupuncture can be performed
and can allow double-blinded studies.
Trial status
This trial is currently recruiting participants.
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